Clinical investigation has revealed that individuals face challenges in adapting to their gruesome employee-roles after undergoing a back intervention program. The aim of this research was to investigate the back-rehabilitated patient's perspectives and understandings of the diffi culties faced while adapting as employees. Research aimed to extract the patient's perspectives and understandings of barriers, facilitators and adaptive procedures which infl uenced their capability to continue their employee-roles. Qualitative investigation method was used for investigating the study topic. Focus groups comprised of broad questions followed by probing were utilized to obtain detailed descriptions about the client's understandings and perspectives. Recommendations involved developing the insight of stakeholders regarding early, valuable on-job training, initiating health-promotion by teaching in the workplace and in the society, along with improving fl exible job and health policy. Results of the investigation signify that the goal of physiotherapy and extent of service to back injured patients needs to rebuild.
Monomeric C-reactive protein (mCRP) is now accepted as having a key role in modulating inflammation and in particular, has been strongly associated with atherosclerotic arterial plaque progression and instability and neuroinflammation after stroke where a build-up of the mCRP protein within the brain parenchyma appears to be connected to vascular damage, neurodegenerative pathophysiology and possibly Alzheimer's Disease (AD) and dementia. Here, using immunohistochemical analysis, we wanted to confirm mCRP localization and overall distribution within a cohort of AD patients showing evidence of previous infarction and then focus on its co-localization with inflammatory active regions in order to provide further evidence of its functional and direct impact. We showed that mCRP was particularly seen in large amounts within brain vessels of all sizes and that the immediate micro-environment surrounding these had become laden with mCRP positive cells and extra cellular matrix. This suggested possible leakage and transport into the local tissue. The mCRP-positive regions were almost always associated with neurodegenerative, damaged tissue as hallmarked by co-positivity with pTau and β-amyloid staining. Where this occurred, cells with the morphology of neurons, macrophages and glia, as well as smaller microvessels became mCRP-positive in regions staining for the inflammatory markers CD68 (macrophage), interleukin-1 beta (IL-1β) and nuclear factor kappa B (NFκB), showing evidence of a perpetuation of inflammation. Positive staining for mCRP was seen even in distant hypothalamic regions. In conclusion, brain injury or inflammatory neurodegenerative processes are strongly associated with mCRP localization within the tissue and given our knowledge of its biological properties, it is likely that this protein plays a direct role in promoting tissue damage and supporting progression of AD after injury.
The current scientific community is facing a daunting challenge to unravel reliable natural compounds with realistic potential to treat neurological disorders such as Alzheimer’s disease (AD). The reported compounds/drugs mostly synthetic deemed the reliability and therapeutic potential largely due to their complexity and off-target issues. The natural products from nutraceutical compounds emerge as viable preventive therapeutics to fill the huge gap in treating neurological disorders. Considering that Alzheimer’s disease is a multifactorial disease, natural compounds offer the advantage of a multitarget approach, tagging different molecular sites in the human brain, as compared with the single-target activity of most of the drugs so far used to treat Alzheimer’s disease. A wide range of plant extracts and phytochemicals reported to possess the therapeutic potential to Alzheimer’s disease includes curcumin, resveratrol, epigallocatechin-3-gallate, morin, delphinidins, quercetin, luteolin, oleocanthal, and other phytochemicals such as huperzine A, limonoids, and azaphilones. Reported targets of these natural compounds include inhibition of acetylcholinesterase, amyloid senile plaques, oxidation products, inflammatory pathways, specific brain receptors, etc. We tenaciously aimed to review the in-depth potential of natural products and their therapeutic applications against Alzheimer’s disease, with a special focus on a diversity of medicinal plants and phytocompounds and their mechanism of action against Alzheimer’s disease pathologies. We strongly believe that the medicinal plants and phytoconstituents alone or in combination with other compounds would be effective treatments against Alzheimer’s disease with lesser side effects as compared to currently available treatments.
Dysmenorrhea is the term for describing complex menstrual flow and painful spasmodic cramps during menstruation, and pain without any pathology is considered Primary Dysmenorrhea (PD). It is the most frequent ailment among women of all ages and races. The pain is dull and throbbing in character and occurs in the lower back and abdomen. Symptoms commonly appear 6 to 12 months after menarche, with the most significant incidence in the late teen and early twenties. Physical exercise is nearly a new non-medical intervention to relieve PD associated pain. Aerobics, stretching and Resistive exercises for 8-12 weeks, either supervised or unsupervised, relieves pain. Exercises are believed to cause hormonal changes in the uterine lining, which reduces PD symptoms. Researchers have presumed different pain-relieving methods, ranging from non-opioids to opioids to hormonal for variations in pain sensitivity. Exercise-induced analgesia provides the central pathway as the primary mechanism for pain reduction while, another way to reducing pain in PD may be a hormonal interaction. The hormonal changes causing exercise-induced pain modulation during the menstruation cycle is not clearly understood and the interaction and activation of all the central and endocrine components, which is a complex mechanism, is also not explained clearly. This study briefly reviews the physiological mechanism of Exercise-induced analgesia and its potent roles in controlling the pathogenesis of PD for pain relief.
Background: The knee joint is one of the most important joints in terms of its functions of providing great stability, movement and weight bearing. Among the contributors to knee joint stability, there is the anterior cruciate ligament (ACL). Kinesiophobia is said to be the fear of movement or the fear of re-injury. Kinesiophobia is the most extreme form of fear of movement, and it is defined as an excessive, irrational, and debilitating fear of physical movement and activity resulting from a feeling of vulnerability to painful injury or re-injury. Aim: To estimate the prevalence and effect of kinesiophobia among patients with ACL reconstruction in the Aseer region, in southern Saudi Arabia. Methodology: A descriptive cross-sectional approach was used involving those patients who underwent ACL reconstruction surgery in Aseer Central Hospital during the period of October 2017 to October 2019. The Tampa Scale for Kinesiophobia (TSK) and ACL—Return to Sport after Injury (ACL-RSI) scale were used to determine kinesiophobia and the readiness to return to sport after ACL injury or reconstructive surgery. Result: The research included 130 ACL reconstruction patients with ages ranging from 18 to 45 years with a mean age of 27.2 + 7.5 years. More than 97% of the participants were males. In 67.7% of the cases, the right leg was affected. A total of 10.8% of the patients recorded a low level of kinesiophobia, while only 6.9% recorded a high level. Conclusions: In conclusion, the study revealed that among patients who underwent ACL reconstruction, kinesiophobia was at a moderate level. Kinesiophobia was recorded more among middle-aged patients who waited a long time from the onset of injury until the ACL reconstruction surgery time.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.